International
The Morning Science

What science found today

‹
 

Research

ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

eLife · By Ali Mobeen ·

The Brief

  • A mouse study reports that ITK deficiency protects against autoimmune pulmonary hemorrhage.
  • The protective effect is attributed to promoting amphiregulin-producing regulatory T cells.
  • Pulmonary hemorrhage is a life-threatening manifestation of systemic autoimmunity that disrupts the alveolar capillary barrier and has high mortality.

Why it matters

The study identifies a molecular checkpoint that may shift destructive inflammation toward immune regulation in a life-threatening autoimmune complication, which is relevant to researchers studying autoimmunity. The evidence comes from mice, so it does not yet show effects in humans.

Who’s affected

  • immunologists and researchers studying autoimmune disease

Pulmonary hemorrhage (PH) is a life-threatening manifestation of systemic autoimmunity caused by immune-mediated disruption of the alveolar capillary barrier. Despite high mortality, the molecular checkpoints that shift destructive inflammation toward protective immune regulation…

Timeline

  1. Study published in eLife

  2. eLife: latest articles

    ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells

How do you feel about this?

0 Comments

    ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells – The Morning Science